日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Posttranscriptional activity of the eukaryotic translation initiation factor eIF4E contributes to HoxA9-driven leukemogenesis

真核翻译起始因子eIF4E的转录后活性促进HoxA9驱动的白血病发生。

Zhou, Fang; Culjkovic-Kraljacic, Biljana; Bach, Christian; Feng, Li; Mishima, Yuta; Borden, Katherine L B; Tenen, Daniel G

Posttranscriptional activity of eIF4E contributes to HoxA9-driven leukemogenesis.

eIF4E 的转录后活性促进 HoxA9 驱动的白血病发生。

Zhou Fang, Culjkovic-Kraljacic Biljana, Bach Christian, Feng Li, Mishima Yuta, Borden Katherine L B, Tenen Daniel G

XPO1 Enables Adaptive Regulation of mRNA Export Required for Genotoxic Stress Tolerance in Cancer Cells

XPO1 能够自适应地调节癌细胞对基因毒性应激耐受性所需的 mRNA 输出

Rossella Marullo #, Sarah C Rutherford #, Maria V Revuelta, Nahuel Zamponi, Biljana Culjkovic-Kraljacic, Nikita Kotlov, Nicolás Di Siervi, Juan Lara-Garcia, John N Allan, Jia Ruan, Richard R Furman, Zhengming Chen, Tsiporah B Shore, Adrienne A Phillips, Sebastian Mayer, Jingmei Hsu, Koen van Besien,

Medicinal Chemistry and NMR Driven Discovery of Novel UDP-glucuronosyltransferase 1A Inhibitors That Overcome Therapeutic Resistance in Cells

利用药物化学和核磁共振技术发现新型UDP-葡萄糖醛酸转移酶1A抑制剂,克服细胞治疗耐药性

Osborne, Michael J; Sulekha, Anamika; Culjkovic-Kraljacic, Biljana; Gasiorek, Jadwiga; Ruediger, Edward; Jolicouer, Eric; Marinier, Anne; Assouline, Sarit; Borden, Katherine L B

eIF4E orchestrates mRNA processing, RNA export and translation to modify specific protein production

eIF4E 调控 mRNA 加工、RNA 输出和翻译,从而调节特定蛋白质的产生。

Mars, Jean-Clément; Culjkovic-Kraljacic, Biljana; Borden, Katherine L B

The eukaryotic translation initiation factor eIF4E reprograms alternative splicing

真核翻译起始因子 eIF4E 重新编程选择性剪接

Mehdi Ghram #, Gavin Morris #, Biljana Culjkovic-Kraljacic #, Jean-Clement Mars, Patrick Gendron, Lucy Skrabanek, Maria Victoria Revuelta, Leandro Cerchietti, Monica L Guzman, Katherine L B Borden

Molecular targeting of the UDP-glucuronosyltransferase enzymes in high-eukaryotic translation initiation factor 4E refractory/relapsed acute myeloid leukemia patients: a randomized phase II trial of vismodegib, ribavirin with or without decitabine

针对高真核翻译起始因子4E难治/复发性急性髓系白血病患者的UDP-葡萄糖醛酸转移酶进行分子靶向治疗:一项维莫德吉、利巴韦林联合或不联合地西他滨的随机II期临床试验

Assouline, Sarit; Gasiorek, Jadwiga; Bergeron, Julie; Lambert, Caroline; Culjkovic-Kraljacic, Biljana; Cocolakis, Eftihia; Zakaria, Chadi; Szlachtycz, David; Yee, Karen; Borden, Katherine L B

Identification and Characterization of the Interaction Between the Methyl-7-Guanosine Cap Maturation Enzyme RNMT and the Cap-Binding Protein eIF4E

甲基-7-鸟苷帽成熟酶 RNMT 与帽结合蛋白 eIF4E 之间相互作用的鉴定和表征

Michael J Osborne, Laurent Volpon, Mina Memarpoor-Yazdi, Shubhadra Pillay, Aksharh Thambipillai, Sylwia Czarnota, Biljana Culjkovic-Kraljacic, Christian Trahan, Marlene Oeffinger, Victoria H Cowling, Katherine L B Borden

The eukaryotic translation initiation factor eIF4E elevates steady-state m7G capping of coding and noncoding transcripts

真核翻译起始因子 eIF4E 提升编码和非编码转录本的稳态 m7G 封端

Biljana Culjkovic-Kraljacic, Lucy Skrabanek, Maria V Revuelta, Jadwiga Gasiorek, Victoria H Cowling, Leandro Cerchietti, Katherine L B Borden

Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia

使用利巴韦林靶向 EIF4E 信号治疗婴儿急性淋巴细胞白血病

Karen A Urtishak #, Li-San Wang #, Biljana Culjkovic-Kraljacic #, James W Davenport, Patrizia Porazzi, Tiffaney L Vincent, David T Teachey, Sarah K Tasian, Jonni S Moore, Alix E Seif, Shenghao Jin, Jeffrey S Barrett, Blaine W Robinson, I-Ming L Chen, Richard C Harvey, Martin P Carroll, Andrew J Carr